NeuroPace Q2 EPS $(0.18) Beats $(0.20) Estimate, Sales $22.826M Beat $22.654M Estimate
NeuroPace (NASDAQ: NPCE ) reported quarterly losses of $(0.18) per share which beat the analyst consensus estimate of $(0.20) by 10 percent. This is a 30.77 percent increase over losses of $(0.26) per share from the same period last year. The company reported quarterly sales of $22.826 million which beat the analyst consensus estimate of $22.654 million by 0.76 percent. This is a 17.05 percent increase over sales of $19.501 million the same period last year.
NeuroPace (NASDAQ: NPCE ) reported quarterly losses of $(0.18) per share which beat the analyst consensus estimate of $(0.20) by 10 percent.
This is a 30.77 percent increase over losses of $(0.26) per share from the same period last year.
The company reported quarterly sales of $22.826 million which beat the analyst consensus estimate of $22.654 million by 0.76 percent.
This is a 17.05 percent increase over sales of $19.501 million the same period last year.